CD317 (PDCA-1), Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-CD317 (PDCA-1), Mouse antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD317 (PDCA-1), Mouse |
| Clone | REA818 |
| Host Species | Recombinant Human |
| Reactive Species | mouse |
| Isotype | IgG1 |
| Format | PE-Vio 770 conjugate |
| Size | 30 µg in 200 µL |
| Concentration | 1:50 |
| Applications | Flow cytometry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | CD317 (PDCA-1) Antibody, anti-mouse, PE-Vio® 770, REAfinity™. Clone REA818 recognizes the mouse CD317 antigen, also known as mouse plasmacytoid dendritic cell antigen-1 (PDCA-1) or BST2. CD317 is specifically expressed on mouse PDCs, a subset of CD11c+ dendritic cells detected at low frequency in all lymphoid tissues, peripheral blood, and some non-lymphoid tissues. In mouse spleen, bone marrow, and lymph nodes, CD317 is exclusively expressed on cells which are CD11clow, Ly-6Chigh, CD45R (B220)+, MHC class IIlow, CD8alow/-, CD80low/-, CD86-, CD40-, CD11b-, CD90-, CD49b (DX5)-, CD3-, CD19-, i.e., on cells with the phenotype of mouse PDCs. Multi-color fluorescent staining of spleen cells clearly revealed that all CD11clow Ly-6Chigh CD45R (B220)+ PDCs are PDCA-1+ and that PDCA-1 expression is restricted to PDCs. | Additional information: Clone REA818 displays negligible binding to Fc receptors. |
| Immunogen | n/a |
| Other Names | BST2, Bst-2, C87040, CD317, DAMP-1, GREG, mPDCA-1 |
| Gene, Accession # | Gene ID: 69550 |
| Catalog # | 130-112-379 |
| Price | $167 |
| Order / More Info | CD317 (PDCA-1), Mouse Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Krug, A. et al. (2004) TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21: 107-119. | Colonna, M. et al. (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226. | Fallarino, F. et al. (2005) Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. Int. Immunol. 17: 1429-1438. | Xu, H. et al. (2007) Identification of novel dendritic cell populations in normal mouse retina. Invest. Ophthalmol. Vis. Sci. 48 (4): 1701-1710. | Yoo, J. K. et al. (2010) Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity. J. Exp. Med. 207 (7): 1435-1451. | Daito, H. et al. (2011) Mycobacterial hypersensitivity pneumonitis requires TLR9-MyD88 in lung CD11b+ CD11c+ cells. Eur. Respir. J. 38 (3): 688-701. | Julian, M. W. et al. (2012) Mitochondrial transcription factor A serves as a danger signal by augmenting plasmacytoid dendritic cell responses to DNA. J Immunol 189 (1): 433-443. | Matsui, H. et al. (2012) Mechanism of action of inhibition of allergic immune responses by a novel antedrug TLR7 agonist. J Immunol 189 (11): 5194-5205. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies